These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Role of the implantable cardioverter-defibrillator in secondary prevention of sudden death in hypertrophic cardiomyopathy patients]. Primo J, Geelen P, Brugada J, Lorga Filho A, Mont L, Wellens F, Valentino M, Brugada P. Rev Port Cardiol; 1998 Oct; 17(10):783-7. PubMed ID: 9865087 [No Abstract] [Full Text] [Related]
23. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators? Maron BJ, Olivotto I, Maron MS. Eur Heart J; 2006 Aug; 27(16):1895-7. PubMed ID: 16818455 [No Abstract] [Full Text] [Related]
24. Hypertrophic cardiomyopathy. Sudden death is rare in young people with hypertrophic cardiomyopathy. Wald DS, Law M. BMJ; 2006 Jul 08; 333(7558):96-7; author reply 97. PubMed ID: 16825235 [No Abstract] [Full Text] [Related]
33. Risk assessment of the occurrence of sudden death related to hypertrophic cardiomyopathy in Dakar. Sarr SA, Dodo B, Babaka K, Aw F, Bodian M, Ndiaye MB, Kane A, Diao M, Ba SA. Cardiovasc J Afr; 2018 Jan 23; 29(1):e1-e5. PubMed ID: 29582881 [Abstract] [Full Text] [Related]
34. Should ICDs be implanted in all patients with dilated cardiomyopathy and unexplained syncope? Josephson ME. J Am Coll Cardiol; 1999 Jun 23; 33(7):1971-3. PubMed ID: 10362201 [No Abstract] [Full Text] [Related]
35. The price and value of implantable cardioverter defibrillators in hypertrophic cardiomyopathy. Chen Y, O'Mahony C. Int J Cardiol; 2020 Jul 15; 311():52-53. PubMed ID: 32299632 [No Abstract] [Full Text] [Related]
36. Gaps in Evidence for Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy. Pelliccia F, Gersh BJ, Camici PG. Circulation; 2021 Jan 12; 143(2):101-103. PubMed ID: 33428428 [No Abstract] [Full Text] [Related]
37. 33-year-old man with syncope. Sheldon SH, Orme NM, Klarich KW. Mayo Clin Proc; 2011 Jul 12; 86(7):681-4. PubMed ID: 21719622 [No Abstract] [Full Text] [Related]
38. Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart. Saberi S, Day SM. Circulation; 2018 Jan 30; 137(5):419-421. PubMed ID: 29378753 [No Abstract] [Full Text] [Related]
39. The editor's roundtable: sudden cardiac death in athletes. Friedewald VE, Maron BJ, Roberts WC. Am J Cardiol; 2007 Nov 01; 100(9):1451-9. PubMed ID: 17950807 [No Abstract] [Full Text] [Related]
40. Amid the fourth lustrum after the description of Brugada syndrome: controversies over? Brugada P. Europace; 2009 Apr 01; 11(4):412-3. PubMed ID: 19244257 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]